Additionally, the incorporation of TRAIL in iMSC (iMSC-TRAIL) via site-specific integration into ribosomal DNA resulted in inducing apoptosis in melanoma, liver, breast, and lung cancers in vitro and inhibiting tumor growth through the activation of apoptotic pathways in vivo [83]. This evidence concerns the gene TNFSF10 and lung cancer.